Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Jemperli achieves 76% complete response rate in Phase II rectal cancer trial


Mo-Rez shows 62% response rate in platinum-resistant ovarian cancer


Sofe-M combination shows 79% response rate in platinum-sensitive ovarian cancer


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

From Product Characterization to Clinical Reliable Specifications

Presented by André Mischo, Associate Director Science & Technology at Novartis
11th May 2022


Impact of Depth Filtration on Disulfide Bond Reduction during Downstream Processing of Monoclonal Antibodies from CHO Cell Cultures

Presented by Brian O' Mara, Senior Research Scientist I at Bristol-Myers Squibb and Alexei Voloshin, Global Application Strategy Specialist at 3M Separation and Purification Sciences Division
08th October 2018


Strategies to overcome Low Endotoxin Recovery using the conventional LAL assay

Presented by Dr. Ruth Daniels, Janssen & Kevin L. Williams, BIOMÉRIEUX
28th June 2018


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia